Fairfield, Bush & Co’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.15M | Buy |
2,187
+30
| +1% | +$15.8K | 0.65% | 43 |
|
2025
Q1 | $1.37M | Buy |
2,157
+193
| +10% | +$122K | 0.87% | 36 |
|
2024
Q4 | $1.4M | Buy |
1,964
+125
| +7% | +$89K | 0.82% | 37 |
|
2024
Q3 | $1.93M | Sell |
1,839
-137
| -7% | -$144K | 1.15% | 27 |
|
2024
Q2 | $2.08M | Sell |
1,976
-6
| -0.3% | -$6.31K | 1.24% | 24 |
|
2024
Q1 | $1.91M | Sell |
1,982
-76
| -4% | -$73.2K | 1.13% | 26 |
|
2023
Q4 | $1.81M | Buy |
2,058
+123
| +6% | +$108K | 1.06% | 27 |
|
2023
Q3 | $1.59M | Buy |
1,935
+115
| +6% | +$94.7K | 1.04% | 28 |
|
2023
Q2 | $1.31M | Buy |
1,820
+95
| +6% | +$68.3K | 0.36% | 60 |
|
2023
Q1 | $1.42M | Sell |
1,725
-245
| -12% | -$201K | 0.5% | 50 |
|
2022
Q4 | $1.42M | Buy |
1,970
+171
| +10% | +$123K | 0.94% | 28 |
|
2022
Q3 | $1.24M | Buy |
1,799
+155
| +9% | +$107K | 0.87% | 31 |
|
2022
Q2 | $972K | Sell |
1,644
-170
| -9% | -$101K | 0.57% | 42 |
|
2022
Q1 | $1.27M | Sell |
1,814
-637
| -26% | -$445K | 0.64% | 40 |
|
2021
Q4 | $1.55M | Sell |
2,451
-50
| -2% | -$31.6K | 0.74% | 35 |
|
2021
Q3 | $1.51M | Sell |
2,501
-245
| -9% | -$148K | 0.49% | 53 |
|
2021
Q2 | $1.53M | Buy |
2,746
+1,292
| +89% | +$722K | 0.42% | 52 |
|
2021
Q1 | $688K | Buy |
1,454
+565
| +64% | +$267K | 0.2% | 96 |
|
2020
Q4 | $429K | Sell |
889
-496
| -36% | -$239K | 0.13% | 113 |
|
2020
Q3 | $775K | Buy |
1,385
+805
| +139% | +$450K | 0.25% | 80 |
|
2020
Q2 | $362K | Buy |
+580
| New | +$362K | 0.13% | 102 |
|
2017
Q4 | – | Sell |
-500
| Closed | -$224K | – | 160 |
|
2017
Q3 | $224K | Hold |
500
| – | – | 0.07% | 137 |
|
2017
Q2 | $246K | Buy |
+500
| New | +$246K | 0.08% | 130 |
|
2016
Q4 | – | Sell |
-500
| Closed | -$201K | – | 151 |
|
2016
Q3 | $201K | Buy |
+500
| New | +$201K | 0.07% | 144 |
|
2016
Q1 | – | Sell |
-500
| Closed | -$271K | – | 139 |
|
2015
Q4 | $271K | Hold |
500
| – | – | 0.09% | 120 |
|
2015
Q3 | $233K | Hold |
500
| – | – | 0.1% | 116 |
|
2015
Q2 | $255K | Hold |
500
| – | – | 0.08% | 147 |
|
2015
Q1 | $226K | Hold |
500
| – | – | 0.07% | 160 |
|
2014
Q4 | $205K | Buy |
+500
| New | +$205K | 0.06% | 168 |
|